(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CANCER COMMUNICATIONS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CANCER COMMUNICATIONS

ST13

US500000078940396

Class

35, 41

Filing

78940396

Registration

3305030

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

02/04/2017

Trademark type

Word

Nice classes

35, 41

Filing date

07/28/2006

Registration date

10/02/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/21/2017

Last transaction

02/04/2017

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

01/01/2007

First use in commerce

01/01/2007

Drawing code

4

Owner type

03

Owner location

Irving, TX, US

Examiner

ROSSMAN, MARY

Law office

L90

Current location

TMEG LAW OFFICE 109

Holders and representatives

Holders

Customized Pharmaceutical Learning Systems, Inc.

Representatives

Customized Pharmaceutical Learning Systems, Inc.

Technical classification

Nice Classes

Class 35Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business marketing consulting services

Class 41

Educational servicesconducting seminarsconferencessymposiaworkshops and speaker training in the fields of oncologypharmaceuticalsexecutive developmentthe distribution of course materials in connection therewith

Publications

History of USPTO decisions and trademark events.

34 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

01/21/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/21/2017

9G8P

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

01/21/2017

8PRT

REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED

01/21/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/21/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

11/10/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/10/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/02/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/15/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/15/2016

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

09/26/2013

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

09/25/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/25/2013

8.AF

REGISTERED - SEC. 8 (6-YR) FILED

09/24/2013

ES8R

TEAS SECTION 8 RECEIVED

09/24/2013

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

10/02/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/24/2007

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

08/13/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

08/06/2007

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/06/2007

GNEA

EXAMINERS AMENDMENT E-MAILED

08/06/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/06/2007

IUAA

USE AMENDMENT ACCEPTED

08/06/2007

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

07/09/2007

ALIE

ASSIGNED TO LIE

07/09/2007

IUAF

USE AMENDMENT FILED

06/25/2007

EAAU

TEAS AMENDMENT OF USE RECEIVED

06/25/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/25/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/25/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/25/2007

GNRT

NON-FINAL ACTION E-MAILED

12/26/2006

CNRT

NON-FINAL ACTION WRITTEN

12/26/2006

DOCK

ASSIGNED TO EXAMINER

12/22/2006

NWAP

NEW APPLICATION ENTERED

08/02/2006

Continuous trademark protection

Get notified about every new filing that threatens CANCER COMMUNICATIONS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.